– Reuters
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad’s CRISPR Patents
The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard…
Related Posts
Loop Capital Downgrades FedEx to Hold, Lowers Price Target to $202
Loop Capital analyst Rick Paterson downgrades FedEx (NYSE:FDX) from Buy to Hold and lowers the price target from $339 to $202.
Wipro: Q2 Earnings Insights
Wipro (NYSE:WIT) reported its Q2 earnings results on Wednesday, October 12, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Wipro missed estimated earnings by 14.29%, reporting an EPS of $0.06 versus an estimate of $0.07.
Olaplex Hldgs Q3 Adj. EPS $0.11 Beats $0.09 Estimate, Sales $161.60M Beat $145.23M Estimate
Olaplex Hldgs (NASDAQ:OLPX) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.09 by 22.22 percent. The company reported quarterly sales of $161.60 million which beat the